Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma. - Wikidata - awgldk - TriplyDB

Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma.

Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma.

http://www.wikidata.org/entity/Q38838354

about

Targeting glioma stem-like cell survival and chemo-resistance through inhibition of lysine-specific histone demethylase KDM2B.Heparan sulfate accumulation and perlecan/HSPG2 up-regulation in tumour tissue predict low relapse-free survival for patients with glioblastoma.Rationale and design of the 500-patient, 3-year, and prospective Vigilant ObservatIon of GlIadeL WAfer ImplaNT registry.Structural and functional intratumor heterogeneities in glioblastoma: a spacetime odyssey at single-cell level.Glioblastoma: new therapeutic strategies to address cellular and genomic complexity.Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach.RESTRICTION OF γ34.5-DELETED ONCOLYTIC HERPES SIMPLEX VIRUS REPLICATION IN GLIOBLASTOMA STEM-LIKE CELLS.CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges Primary cilium and glioblastoma

P2860

Q47845301-DAED602C-4B77-4943-B394-5A64DCB67DDF Q47871189-B9DD5AA0-2CB3-4ADD-9A6B-2813CD81EAC3 Q50071181-639DA256-1D92-407E-9790-5BED59AF61A3 Q52096352-BA30F2BD-8D5A-4E42-AE08-7E3245C90713 Q52366335-0CACF1C6-00E6-4EE0-8FDE-A5CC8E97929D Q52629217-801E13A3-0602-4FE4-BF35-604ECC728E25 Q52715769-03FFC31A-9382-47DD-BF85-E90468FA0BD5 Q55456991-4F22C8EF-81CB-4B61-924A-AC309B3DB844 Q57291659-F45094A7-97DB-49BB-853F-027F73E0E875 Q57298233-00BBB6E3-F127-4F33-B487-B9B52EDB40E5

P2860

Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma.

http://www.wikidata.org/entity/Q38838354

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Intratumoral heterogeneity: pa ...... relapse in human glioblastoma.

@en

type

label

Intratumoral heterogeneity: pa ...... relapse in human glioblastoma.

@en

prefLabel

Intratumoral heterogeneity: pa ...... relapse in human glioblastoma.

@en

P1433

Q38838354-8474261C-5EFF-477E-92C7-AAA8EF8B5F4A

P1476

Q38838354-01DC4DE0-C703-471C-B8B7-8640322B8665

P2093

Q38838354-00D6369B-9E14-42D6-96F2-E633C4B7C240

Q38838354-1C02888D-EAED-4CBF-95CA-A945FAAE17D1

Q38838354-B9497DF5-E84E-4984-A3D5-BB32B4D2BFE1

Q38838354-BB66317E-3137-49FC-850E-4FE4D0493D9C

Q38838354-E3078496-7CBE-4D45-A0C1-50A373CA769A

P2860

Q38838354-036A51B6-D569-4152-A3ED-D5B597C8CBCC

Q38838354-0B3C87AB-7754-4668-80BC-466CF40982F5

Q38838354-0BDA8515-6D65-40BE-81C5-8F5DB176D439

Q38838354-0D69E347-5C1C-4B46-B16B-00FB71634218

Q38838354-1200EFF5-5707-465A-BC87-3B65D4BF4657

Q38838354-21DEFF8E-4275-4645-BCAB-FE8523670E34

Q38838354-28EDDFD0-0EA8-4B72-A022-F49A94924733

Q38838354-2932E268-4897-47B1-8CCF-8B41E7D8BE9A

Q38838354-2AFBC063-A349-442C-ADE2-3D1235804378

Q38838354-2B892C96-59B2-45F4-9DDA-07355B61B003

P304

Q38838354-442BE7BA-74B3-405A-9620-110595F39A90

P31

Q38838354-6F38D613-8ADA-4D3D-8D45-83E6B8F58211

P356

Q38838354-79FF8C11-825D-412B-B6AA-962BD52252CE

P433

Q38838354-81CBC077-EDA3-4608-8757-3134F9E806FA

P478

Q38838354-4C82EFEF-C244-4671-8725-EDCDDC84EB51

P50

Q38838354-7A9EE103-CCCC-40C8-9873-6DF0D0A22D27

Q38838354-D359EAD6-1738-480D-A583-12D68C900B1E

P577

Q38838354-DD1D0AFA-E0D2-416A-879E-A80ADC040C4C

P698

Q38838354-DD956710-908E-4F8D-A7FF-911D127557AF

P356

P1433

Annals of Oncology

P1476

Intratumoral heterogeneity: pa ...... relapse in human glioblastoma.

@en

P2093

C Venugopal

http://www.w3.org/2001/XMLSchema#string

J Moffat

http://www.w3.org/2001/XMLSchema#string

P Vora

http://www.w3.org/2001/XMLSchema#string

S K Singh

http://www.w3.org/2001/XMLSchema#string

S S Sidhu

http://www.w3.org/2001/XMLSchema#string

P2860

Cancerous stem cells can arise from pediatric brain tumors

Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

The 2007 WHO classification of tumours of the central nervous system

Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine

Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells

MGMT gene silencing and benefit from temozolomide in glioblastoma.

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

P304

1448-1456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDX169

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Charles Swanton

P577

2017-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28407030

http://www.w3.org/2001/XMLSchema#string